Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome

Conditions:   Kaposiform Hemangioendothelioma;   Kasabach Merritt Phenomenon Interventions:   Drug: Sirolimus;   Drug: Prednisolone Sponsor:   West China Hospital Recruiting - verified June 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials